New Oregon Freeze Dry Lab Aims to Capitalize on Biopharma Trends
The facility will develop and test oral immunotherapy drugs in Oregon, but the company may look elsewhere if scaling is required. Last month, biote...
The facility will develop and test oral immunotherapy drugs in Oregon, but the company may look elsewhere if scaling is required. Last month, biotech manufacturer Oregon Freeze Dry opened its newest research and development facility in Albany, in part to develop and test an ingestible COVID-19 vaccine as well as other immunotherapy products. The $7.5 million construction sits next to the company's world headquarters, will develop orally ingested alternatives to immunotherapy treatments — a trend company leadership says is on the upswing.